If you liked this article you might like

Actelion Is a Perfect Fit for Sanofi, but Probably Too Expensive: Exane BNP
5 Things You Must Know Before the Market Opens Tuesday
European Stocks Slip Lower, Italy Gains in Mixed Start to Trading
Actelion Surges on Report of Sanofi Challenge to J&J Takeover Bid